UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes

Current pharmaceutical design, 2020-01, Vol.26 (43), p.5637-5649

2020

Volltextzugriff (PDF)

The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7326

2022

Volltextzugriff (PDF)

Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome

Current pharmaceutical design, 2021-01, Vol.27 (35), p.3729-3740

2021

Volltextzugriff (PDF)

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers

Current pharmaceutical design, 2019-01, Vol.25 (35), p.3704-3714

2019

Volltextzugriff (PDF)

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Frontiers in cardiovascular medicine, 2021, Vol.8, p.787761-787761

2021

Volltextzugriff (PDF)

New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry

Diabetes therapy, 2021-02, Vol.12 (2), p.461-464

2021

Volltextzugriff (PDF)

Statin intolerance: new data and further options for treatment

Current opinion in cardiology, 2021-07, Vol.36 (4), p.487-493

2021

Volltextzugriff (PDF)

Post-COVID syndrome, inflammation, and diabetes

Journal of diabetes and its complications, 2022-11, Vol.36 (11), p.108336-108336, Article 108336

2022

Volltextzugriff (PDF)

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

Biochimica et biophysica acta. Molecular basis of disease, 2022-12, Vol.1868 (12), p.166559-166559, Article 166559

2022

Volltextzugriff (PDF)

Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity

Journal of Mind and Medical Sciences, 2019-05, Vol.6 (1), p.157-161

2019

Volltextzugriff (PDF)

Microbiota signatures in type-2 diabetic patients with chronic kidney disease - A Pilot Study

Journal of Mind and Medical Sciences, 2019-05, Vol.6 (1), p.130-136

2019

Volltextzugriff (PDF)

Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region?

Current vascular pharmacology, 2022-01, Vol.20 (4), p.311-312

2022

Volltextzugriff (PDF)

Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes

International journal of clinical practice (Esher), 2021-02, Vol.75 (2), p.e13666-n/a

2021

Volltextzugriff (PDF)

Cardiovascular Risk and Statin Therapy Considerations in Women

Diagnostics (Basel), 2020-07, Vol.10 (7), p.483

2020

Volltextzugriff (PDF)

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review

Nutrients, 2023-05, Vol.15 (10), p.2288

2023

Volltextzugriff (PDF)

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper

Archives of medical science, 2023-01, Vol.19 (4), p.841-864

2023

Volltextzugriff (PDF)

Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group

International journal of cardiology, 2022-10, Vol.365, p.8-18

2022

Volltextzugriff (PDF)

Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel

Diabetes research and clinical practice, 2021-02, Vol.172, p.108535-108535, Article 108535

2021

Volltextzugriff (PDF)

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Current atherosclerosis reports, 2021-10, Vol.23 (10), p.57-57, Article 57

2021

Volltextzugriff (PDF)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)

Diabetes therapy, 2022-04, Vol.13 (4), p.795-810

2022

Volltextzugriff (PDF)

New-Onset Diabetes Mellitus in COVID-19: A Scoping Review

Diabetes therapy, 2024-01, Vol.15 (1), p.33-60

2024

Volltextzugriff (PDF)

Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study

Metabolites, 2020-10, Vol.10 (10), p.392

2020

Volltextzugriff (PDF)

Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel

Experimental and clinical endocrinology & diabetes, 2023-05, Vol.131 (5), p.260-267

2023

Volltextzugriff (PDF)

Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview

Metabolites, 2020-11, Vol.10 (11), p.465

2020

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes

The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel

Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry

Statin intolerance: new data and further options for treatment

Post-COVID syndrome, inflammation, and diabetes

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity

Microbiota signatures in type-2 diabetic patients with chronic kidney disease - A Pilot Study

Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence

Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region?

Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes

Cardiovascular Risk and Statin Therapy Considerations in Women

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper

Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group

Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)

New-Onset Diabetes Mellitus in COVID-19: A Scoping Review

Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study

Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel

Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview

Suchergebnisse filtern